
NZ sharemarket falls 1.2% despite F&P's record result
Record half-year revenue from heavyweight Fisher and Paykel Healthcare couldn’t stop the New Zealand sharemarket falling more than 1%, while Ryman Healthcare again disappointed investors.
Record half-year revenue from heavyweight Fisher and Paykel Healthcare couldn’t stop the New Zealand sharemarket falling more than 1%, while Ryman Healthcare again disappointed investors.